Evidence map›Paper›PMID 37427832›Full record

ArticleGut microbes

Short-term mucosal disruption enables colibactin-producing

Christine Harnack, Hilmar Berger, Lichao Liu, Hans-Joachim Mollenkopf, Till Strowig, Michael Sigal

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Vat-Mediated Mucus Penetration Enables Genotoxic Activity ofInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Contribution of pks+Microorganisms · 2024
    Review
  11. Gut microbiome: decision-makers in the microenvironment of colorectal cancer.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Christine HarnackDepartment of Gastroenterology and Hepatology, Charité - Universitätsmedizin, Berlin, Germany.
Hilmar BergerDepartment of Gastroenterology and Hepatology, Charité - Universitätsmedizin, Berlin, Germany.
Lichao LiuDepartment of Gastroenterology and Hepatology, Charité - Universitätsmedizin, Berlin, Germany.
Hans-Joachim MollenkopfCore Facility Microarray, Genomics, Max Planck Institute for Infection Biology, Berlin, Germany.
Till StrowigDepartment of Microbial Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Michael SigalDepartment of Gastroenterology and Hepatology, Charité - Universitätsmedizin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEHelmholtz Centre for Infection Research · DEMax Planck Institute for Infection Biology · DEMSB Medical School Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colibactin, a bacterial genotoxin produced by

Indexed as

Colitis, UlcerativeGastrointestinal MicrobiomePolyketidesAnimalsEscherichia coliHumansIntestinal MucosaMicePeptidescolibactinPeptidesPolyketidescolibactincolitisE. coliInflammtory bowel diseasesmicrobiotamucosal barrierregenerationstem cells

Identifiers

PMID37427832
PMCPMC10334853
OpenAlexW4383711304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.